ESR1 and breast carcinoma: For example, MGMT overexpression induces resistance to gemcitabine in pancreatic cancer (124), to cisplatin in colorectal cancer (125) and to temozolomide in glioma (126, 127) and estrogen receptor positive breast cancer (128).